These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Fluorescent probes for opioid receptors. Kolb VM; Koman A; Terenius L Life Sci; 1983; 33 Suppl 1():423-6. PubMed ID: 6319896 [TBL] [Abstract][Full Text] [Related]
5. Multiple mu receptors: evidence for mu2 sites in the guinea pig ileum. Gintzler AR; Pasternak GW Neurosci Lett; 1983 Aug; 39(1):51-6. PubMed ID: 6314191 [TBL] [Abstract][Full Text] [Related]
6. A naloxone-steroid hybrid azine with selective and long-acting opioid antagonism at delta receptors in vitro. Koman A; Kolb VM; Terenius L Pharm Res; 1987 Apr; 4(2):147-9. PubMed ID: 2855368 [TBL] [Abstract][Full Text] [Related]
7. Irreversible opiate agonists and antagonists. II. Evidence against a bivalent mechanism of action for opiate azines and diacylhydrazones. Hahn EF; Nishimura S; Goodman RR; Pasternak GW J Pharmacol Exp Ther; 1985 Dec; 235(3):839-45. PubMed ID: 2416909 [TBL] [Abstract][Full Text] [Related]
8. The in vitro pharmacological characterization of naloxone benzoylhydrazone. Berzetei-Gurske IP; White A; Polgar W; DeCosta BR; Pasternak GW; Toll L Eur J Pharmacol; 1995 Apr; 277(2-3):257-63. PubMed ID: 7493617 [TBL] [Abstract][Full Text] [Related]
9. 7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands. Fang X; Larson DL; Portoghese PS J Med Chem; 1997 Sep; 40(19):3064-70. PubMed ID: 9301669 [TBL] [Abstract][Full Text] [Related]
10. Identification of opioid ligands possessing mixed micro agonist/delta antagonist activity among pyridomorphinans derived from naloxone, oxymorphone, and hydromorphone [correction of hydropmorphone]. Ananthan S; Khare NK; Saini SK; Seitz LE; Bartlett JL; Davis P; Dersch CM; Porreca F; Rothman RB; Bilsky EJ J Med Chem; 2004 Mar; 47(6):1400-12. PubMed ID: 14998329 [TBL] [Abstract][Full Text] [Related]
11. Comparative antagonism by naltrexone and naloxone of mu, kappa, and delta agonists. Takemori AE; Portoghese PS Eur J Pharmacol; 1984 Sep; 104(1-2):101-4. PubMed ID: 6094203 [TBL] [Abstract][Full Text] [Related]
12. Dextrorphan binds to opioid receptors in guinea-pig brain membranes and is an antagonist at opioid receptors in myenteric plexus. Goldstein A; Naidu A Proc Natl Acad Sci U S A; 1990 Mar; 87(5):1629-32. PubMed ID: 2155421 [TBL] [Abstract][Full Text] [Related]
13. Activity of mu- and delta-selective opioid agonists in the guinea pig ileum preparation: differentiation into peptide and nonpeptide classes with beta-funaltrexamine. Ward SJ; LoPresti D; James DW J Pharmacol Exp Ther; 1986 Aug; 238(2):625-31. PubMed ID: 3016244 [TBL] [Abstract][Full Text] [Related]
14. Opioid agonists and antagonists. 6-Desoxy-6-substituted lactone, epoxide, and glycidate ester derivatives of naltrexone and oxymorphone. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Appelmans N; Simon EJ J Med Chem; 1985 Jul; 28(7):949-57. PubMed ID: 2409280 [TBL] [Abstract][Full Text] [Related]
15. Irreversible opiate agonists and antagonists: the 14-hydroxydihydromorphinone azines. Hahn EF; Carroll-Buatti M; Pasternak GW J Neurosci; 1982 May; 2(5):572-6. PubMed ID: 6176696 [TBL] [Abstract][Full Text] [Related]
16. Stereostructure-activity relationship of opioid agonist and antagonist bivalent ligands. Evidence for bridging between vicinal opioid receptors. Portoghese PS; Larson DL; Yim CB; Sayre LM; Ronsisvalle G; Lipkowski AW; Takemori AE; Rice KC; Tam SW J Med Chem; 1985 Sep; 28(9):1140-1. PubMed ID: 2993609 [No Abstract] [Full Text] [Related]
17. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand. Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395 [TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different mu receptor subtypes in different tissues. Sayre LM; Larson DL; Takemori AE; Portoghese PS J Med Chem; 1984 Oct; 27(10):1325-35. PubMed ID: 6090663 [TBL] [Abstract][Full Text] [Related]